Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
We explore the rapidly evolving market access landscape in respect to digital health applications in…
Read moreDigital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag…
Read moreWe summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi…
Read moreOur experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel…
Read moreOur experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi…
Read moreThis is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology…
Read moreUK, Canada and United States join forces to streamline process and increase transparency for confide…
Read moreWe explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables …
Read moreEFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe…
Read more